Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Radboud University Medical Center
With
Janssen-Cilag Ltd.
Age
18–any
Sex
MALE
Healthy volunteers
Not accepted
You may be eligible if
Patients with metastatic castration resistant prostate cancer who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated
Age ≥18 years
Feasible to collect blood samples from
Life expectancy of \> 6 months
Measurable disease
Able and willing to give written informed consent prior to screening and enrollment
You may not be if
other anticancer therapies
potent CYP3A4 inducers
herbal medicine that could interfere with abiraterone exposure
